Related Experiment Video
Updated: Jun 6, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Genetic association between serum 25-hydroxyvitamin D levels and functional outcome after ischemic stroke
Yudan Wu1, Tianyu Jin2, Qiongyi Pang2
1Department of Rehabilitation, Ningbo No.6 Hospital, Ningbo, Zhejiang, China.
Background:
Previous observational studies suggest that serum 25-hydroxyvitamin D [25(OH)D] levels may associate with functional outcome after ischemic stroke. However, the causal relationship is not yet defined. Consequently, this study employed two-sample Mendelian Randomization (MR) to elucidate the causal association between serum 25(OH)D levels and functional outcome after ischemic stroke.
Methods:
The genome-wide association study (GWAS) for serum 25(OH)D levels included 417,580 patients of European descent. The GWAS for functional outcome after ischemic stroke is from Genetics of Ischemic Stroke Functional Outcome meta-analysis. Post-stroke outcomes were evaluated using two sets of binary categorical variables (0-2 vs. 3-6 and 0-1 vs. 2-6), and also as ordered modified Rankin Scale (mRS) variables at 3 months. Two-sample MR was used to assess whether the exposure causally affects the outcome. Inverse Variance Weighted (IVW) was the primary method for our MR analysis, which was further supported by sensitivity analyses to ensure the robustness of the results.
Results:
The primary analysis using IVW method indicated no significant casual association between serum 25(OH)D levels and mRS (0-1) vs. mRS (2-6) at 3 months (OR = 0.914, 95% CI: 0.587-1.422, P = 0.69), mRS (0-2) vs. mRS (3-6) at 3 months (OR = 0.699, 95% CI: 0.477-1.025, P = 0.07), and mRS at 3 months (OR = 1.202, 95% CI: 0.875-1.650, P = 0.26). Additionally, after adjusting for stroke severity, the IVW analysis also showed no significant association between serum 25(OH)D levels and mRS (0-1) vs. mRS (2-6) at 3 months (OR = 0.93, 95% CI: 0.55-1.56, P = 0.78), mRS (0-2) vs. mRS (3-6) at 3 months (OR = 0.73, 95% CI: 0.47-1.13, P = 0.16), and mRS at 3 months (OR = 1.09, 95% CI: 0.77-1.54, P = 0.62). The results of the sensitivity analysis suggest that our findings are robust.
Conclusion:
Our MR study offers no genetic evidence supporting the effects of serum 25(OH)D levels on functional outcomes after ischemic stroke. The associations observed in previous observational studies may be attributed to residual confounding factors and reverse causality.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

